FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

765731001: Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674995016 Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
3674997012 Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Is a Cyclopenthiazide and oxprenolol only product in oral dose form true Inferred relationship Some
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Plays role Diuretic therapeutic role true Inferred relationship Some
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has precise active ingredient Oxprenolol hydrochloride true Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has BoSS Oxprenolol hydrochloride true Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has BoSS Cyclopenthiazide true Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength numerator unit mcg true Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has precise active ingredient Cyclopenthiazide true Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has manufactured dose form Extended-release oral tablet true Inferred relationship Some
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has unit of presentation Tablet true Inferred relationship Some
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has BoSS Cyclopenthiazide false Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has precise active ingredient Oxprenolol hydrochloride false Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has BoSS Oxprenolol hydrochloride false Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength numerator value 250 false Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength numerator unit mcg false Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has presentation strength numerator value 160 false Inferred relationship Some 2
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Has precise active ingredient Cyclopenthiazide false Inferred relationship Some 1
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Is a Cyclopenthiazide- and oxprenolol-containing product in oral dose form false Inferred relationship Some
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet Count of base of active ingredient 2 false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start